Delivery of antiretroviral therapy in sub-Saharan Africa

Clinical Infectious Diseases

Volumn 43, Issue 6, 2006, Pages 777-778

  Weller, Ian ^a,b  

^a Camden Primary Care Trust   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CD4 LYMPHOCYTE COUNT; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH;

AFRICA SOUTH OF THE SAHARA; ANTI-RETROVIRAL AGENTS; DELIVERY OF HEALTH CARE; HIV INFECTIONS; HUMANS; PUBLIC HEALTH PRACTICE; TREATMENT FAILURE;

EID: 33748325692     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/507113     Document Type: Note

References (3)

1. UNAIDS and WHO. AIDS epidemic update, December 2005. Available at: http://www.who.int/hiv/epi-update2005_en.pdf. Accessed 4 August 2006.
2. WHO and UNAIDS. Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond: March 2006. Available at: http://www.who.int/hiv/progreport2006_en.pdf. Accessed 4 August 2006.
3. Lawn S, Myer L, Harling G, et al. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 2006;43:770-6 (in this issue).